Fidelity Investments’s Allena Pharmaceuticals ALNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-106,183
| Closed | -$20K | – | 5614 |
|
|
2022
Q2 | $20K | Hold |
106,183
| – | – | ﹤0.01% | 3890 |
|
|
2022
Q1 | $25K | Sell |
106,183
-1,138,826
| -91% | -$472K | ﹤0.01% | 3934 |
|
|
2021
Q4 | $738K | Sell |
1,245,009
-1,051,074
| -46% | -$822K | ﹤0.01% | 2724 |
|
|
2021
Q3 | $2.07M | Hold |
2,296,083
| – | – | ﹤0.01% | 2560 |
|
|
2021
Q2 | $2.98M | Hold |
2,296,083
| – | – | ﹤0.01% | 2461 |
|
|
2021
Q1 | $3.19M | Hold |
2,296,083
| – | – | ﹤0.01% | 2367 |
|
|
2020
Q4 | $2.94M | Buy |
2,296,083
+787,600
| +52% | +$1.1M | ﹤0.01% | 2312 |
|
|
2020
Q3 | $2.23M | Buy |
1,508,483
+32,600
| +2% | +$45.8K | ﹤0.01% | 2288 |
|
|
2020
Q2 | $2.33M | Hold |
1,475,883
| – | – | ﹤0.01% | 2250 |
|
|
2020
Q1 | $1.42M | Hold |
1,475,883
| – | – | ﹤0.01% | 2259 |
|
|
2019
Q4 | $4.03M | Hold |
1,475,883
| – | – | ﹤0.01% | 2102 |
|
|
2019
Q3 | $5.82M | Hold |
1,475,883
| – | – | ﹤0.01% | 2010 |
|
|
2019
Q2 | $6.01M | Sell |
1,475,883
-13,400
| -0.9% | -$73.2K | ﹤0.01% | 2039 |
|
|
2019
Q1 | $10.5M | Sell |
1,489,283
-500
| -0% | -$3.63K | ﹤0.01% | 1849 |
|
|
2018
Q4 | $8.12M | Hold |
1,489,783
| – | – | ﹤0.01% | 1870 |
|
|
2018
Q3 | $16M | Sell |
1,489,783
-375,994
| -20% | -$4.13M | ﹤0.01% | 1778 |
|
|
2018
Q2 | $24.3M | Sell |
1,865,777
-344,600
| -16% | -$4.97M | ﹤0.01% | 1627 |
|
|
2018
Q1 | $23.4M | Sell |
2,210,377
-420,875
| -16% | -$3.52M | ﹤0.01% | 1659 |
|
|
2017
Q4 | $24.7M | Buy |
+2,631,252
| New | +$32.4M | ﹤0.01% | 1626 |
|
Other funds holding ALNA
Fidelity Investments's ALNA Position: Q3 2022 in Review
Fidelity Investments sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 106,183 shares — an estimated $20K sold.
Fidelity Investments first reported a position in ALNA in Q4 2017 and held it in 19 quarters. The position peaked at $24.7M in Q4 2017. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.
- Fidelity Investments reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
- Fidelity Investments sold 106,183 Allena Pharmaceuticals shares in Q3 2022, an estimated $20K.
- Fidelity Investments first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 19 quarters.
- Fidelity Investments's Allena Pharmaceuticals position peaked at $24.7M in Q4 2017.
- 2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.
Based on Fidelity Investments's 13F filing for Q3 2022, filed 10 Nov 2022.